Aurinia Pharmaceuticals Inc [NASDAQ: AUPH] price surged by 6.44 percent to reach at $0.54.
A sum of 5346787 shares traded at recent session while its average daily volume was at 1.36M shares. Aurinia Pharmaceuticals Inc shares reached a high of $9.1 and dropped to a low of $8.32 until finishing in the latest session at $8.93.
The one-year AUPH stock forecast points to a potential upside of 10.7. The average equity rating for AUPH stock is currently 1.50, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Aurinia Pharmaceuticals Inc [AUPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AUPH shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AUPH stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Aurinia Pharmaceuticals Inc shares, keeping their opinion on the stock as Perform, with their previous recommendation back on November 04, 2022. While these analysts kept the previous recommendation, Cantor Fitzgerald dropped their target price from $34 to $25. The new note on the price target was released on May 05, 2022, representing the official price target for Aurinia Pharmaceuticals Inc stock. Previously, the target price had yet another drop from $33 to $31, while Oppenheimer kept a Outperform rating on AUPH stock.
The Price to Book ratio for the last quarter was 3.51, with the Price to Cash per share for the same quarter was set at 2.32. Price to Free Cash Flow for AUPH in the course of the last twelve months was 19.12 with Quick ratio for the last quarter at 5.26.
AUPH Stock Performance Analysis:
Aurinia Pharmaceuticals Inc [AUPH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.23. With this latest performance, AUPH shares gained by 9.71% in over the last four-week period, additionally plugging by 6.56% over the last 6 months – not to mention a drop of -0.56% in the past year of trading.
Insight into Aurinia Pharmaceuticals Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Aurinia Pharmaceuticals Inc [AUPH] shares currently have an operating margin of 21.26% and a Gross Margin at 88.24%. Aurinia Pharmaceuticals Inc’s Net Margin is presently recorded at 16.11%.
Return on Equity for this stock inclined to 7.80%, with Return on Assets sitting at 7.80%.
Aurinia Pharmaceuticals Inc [AUPH] Institutonal Ownership Details
There are presently around $47.22%, or 51.93% of AUPH stock, in the hands of institutional investors. The top three institutional holders of AUPH stocks are: ARMISTICE CAPITAL, LLC with ownership of 11.14 million shares, which is approximately 7.7696%. BLACKROCK INC., holding 9.27 million shares of the stock with an approximate value of $$52.94 million in AUPH stocks shares; and BLACKROCK INC., currently with $$22.67 million in AUPH stock with ownership which is approximately 2.7698%.
